Evidence map›Paper›PMID 33533819›Full record

ArticleRevista da Sociedade Brasileira de Medicina Tropical2021

Role of aminoglycoside-modifying enzymes and 16S rRNA methylase (ArmA) in resistance of Acinetobacter baumannii clinical isolates against aminoglycosides.

Maryam Asadi Jouybari, Mohammad Ahanjan, Bahman Mirzaei, Hamid Reza Goli

Open access · diamondAbstract read
In one paragraph

Article in Revista da Sociedade Brasileira de Medicina Tropical, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
0.7field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 26 citations in OpenAlex.

  1. Virulence · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Resistome, virulome and genomic insights into the silent dissemination ofFrontiers in cellular and infection microbiology · 2026
    Article
  7. Article
  8. Article
  9. Antimicrobial agents and chemotherapy · 2025
    Review
  10. Article
  11. Whole-genome sequencing ofMicrobial genomics · 2025
    Article
  12. Combating Multidrug-ResistantInfection and drug resistance · 2025
    Review
  13. Outsmarting Nightmare: Drug Resistance inThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2025
    Review
  14. TRAIL-mediated armA upregulation enhances the drug resistance ofAmerican journal of translational research · 2025
    Article
  15. Genomic characterization of multidrug-resistant clinicalFrontiers in cellular and infection microbiology · 2025
    Article
  16. Article
  17. Review
  18. Review
  19. Drug‑resistantExperimental and therapeutic medicine · 2023
    Review
  20. Non-antibiotic prevention and treatment againstFrontiers in microbiology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Maryam Asadi JouybariMazandaran University of Medical Sciences, Faculty of Medicine, Molecular and Cell Biology Research Centre, Sari, Iran.
Mohammad AhanjanMazandaran University of Medical Sciences, Faculty of Medicine, Molecular and Cell Biology Research Centre, Sari, Iran.
Bahman MirzaeiZanjan University of Medical Sciences, School of Medicine, Department of Medical Microbiology and Virology, Zanjan, Iran.
Hamid Reza GoliMazandaran University of Medical Sciences, Faculty of Medicine, Molecular and Cell Biology Research Centre, Sari, Iran.ORCID http://orcid.org/0000-0002-2932-1911
Mazandaran University of Medical Sciences · IRZanjan University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThis study aimed to determine the role of genes encoding aminoglycoside-modifying enzymes (AMEs) and 16S rRNA methylase (ArmA) in Acinetobacter baumannii clinical isolates.

methodsWe collected 100 clinical isolates of A. baumannii and identified and confirmed them using microbiological tests and assessment of the OXA-51 gene. Antibiotic susceptibility testing was carried out using disk agar diffusion and micro-broth dilution methods. The presence of AME genes and ArmA was detected by PCR and multiplex PCR.

resultsThe most and least effective antibiotics in this study were netilmicin and ciprofloxacin with 68% and 100% resistance rates, respectively. According to the minimum inhibitory concentration test, 94% of the isolates were resistant to gentamicin, tobramycin, and streptomycin, while the highest susceptibility (20%) was observed against netilmicin. The proportion of strains harboring the aminoglycoside resistance genes was as follows: APH(3')-VIa (aphA6) (77%), ANT(2")-Ia (aadB) (73%), ANT(3")-Ia (aadA1) (33%), AAC(6')-Ib (aacA4) (33%), ArmA (22%), and AAC(3)-IIa (aacC2) (19%). Among the 22 gene profiles detected in this study, the most prevalent profiles included APH(3')-VIa + ANT(2")-Ia (39 isolates, 100% of which were kanamycin-resistant), and AAC(3)-IIa + AAC(6')-Ib + ANT(3")-Ia + APH(3')-VIa + ANT(2")-Ia (14 isolates, all of which were resistant to gentamicin, kanamycin, and streptomycin).

conclusionsHigh minimum inhibitory concentration of aminoglycosides in isolates with the simultaneous presence of AME- and ArmA-encoding genes indicated the importance of these genes in resistance to aminoglycosides. However, control of their spread could be effective in the treatment of infections caused by A. baumannii.

Indexed as

Acinetobacter baumanniiAminoglycosidesAnti-Bacterial AgentsBacterial ProteinsDrug Resistance, BacterialMethyltransferasesMicrobial Sensitivity TestsRNA, Ribosomal, 16SAminoglycosidesAnti-Bacterial AgentsBacterial ProteinsMethyltransferasesRNA, Ribosomal, 16SrRNA (adenosine-O-2'-)methyltransferase

Identifiers

PMID33533819
PMCPMC7849326
OpenAlexW3126885704

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.